Injectable and thermosensitive poly(organophosphazene) hydrogels for a 5-fluorouracil delivery

Authors

  • Sun Mi Lee,

    1. Division of Life Science, Korea Institute of Science and Technology, Seongbuk-gu, Seoul 136791, Korea
    Search for more papers by this author
  • Chang Ju Chun,

    1. Division of Life Science, Korea Institute of Science and Technology, Seongbuk-gu, Seoul 136791, Korea
    Search for more papers by this author
  • Jeong Yun Heo,

    1. Division of Life Science, Korea Institute of Science and Technology, Seongbuk-gu, Seoul 136791, Korea
    2. Department of Materials Science and Engineering, College of Engineering, Seoul National University, Seoul 151-742, Korea
    Search for more papers by this author
  • Soo-Chang Song

    Corresponding author
    1. Division of Life Science, Korea Institute of Science and Technology, Seongbuk-gu, Seoul 136791, Korea
    • Division of Life Science, Korea Institute of Science and Technology, Seongbuk-gu, Seoul 136791, Korea
    Search for more papers by this author

Abstract

The drug solubility and its release profiles of an anticancer drug from an injectable thermosensitive poly(organophosphazene) hydrogel bearing hydrophobic L-isoleucine ethyl ester and hydrophilic α-amino-ω-methoxy-poly(ethylene glycol) with and without hydrolysis-sensitive glycyl lactate ethyl ester or functional glycyl glycine have been investigated. 5-Fluorouracil (5-FU) was used as a model anticancer drug. The aqueous solutions of 5-FU incorporated poly(organophosphazenes) were an injectable fluid state at room temperature and formed a transparent gel at body temperature. The poly(organophosphazene) solution could enhance the solubility of 5-FU and its solubility (34.26 mg/mL) was increased up to 10-fold compared to that in phosphate-buffered saline (3.39 mg/mL, pH 7.4, 4°C). The in vitro drug release profiles from poly(organophosphazene) hydrogels were established in phosphate-buffered saline at pH 7.4 at 37°C and the release of 5-FU was significantly affected by the diffusion-controlled stage. The results suggest that the injectable and thermosensitive poly(organophosphazene) hydrogel is a potential carrier for 5-FU to increase its solubility, control a relatively sustained and localized release at target sites and thus decrease systemic side effects. © 2009 Wiley Periodicals, Inc. J Appl Polym Sci, 2009

Ancillary